A global study published in Nature Medicine has revealed the alarming health impacts of sugary drinks/sugar-sweetened beverages (SSBs), highlighting their contribution to the growing prevalence of Type 2 Diabetes (T2D) and Cardiovascular Disease (CVD) worldwide.
The research, conducted by the Global Dietary Database collaboration, analyzed data from 184 countries, including 450 dietary surveys representing 2.9 million individuals. Findings suggest that sugary drink consumption accounted for 2.2 million new diabetes cases and 1.2 million cardiovascular cases globally in 2020.
Key Regional Insights:
- Latin America and the Caribbean: The highest proportional burden, with 24.4% of diabetes and 11.3% of cardiovascular cases linked to SSB consumption.
- Sub-Saharan Africa: Experienced an 8.8% rise in diabetes burdens and a 4.4% rise in CVD cases between 1990 and 2020.
- United States and Mexico: Showed consistently high impacts, reflecting elevated consumption levels.
Researchers highlighted socioeconomic disparities, with lower education levels correlating with higher vulnerability to SSB-related health risks. Urban residents and younger populations showed higher consumption rates, intensifying disease prevalence in these groups.
Major Findings:
- 12.5 million global DALYs (Disability-Adjusted Life Years) were linked to sugary drink intake in 2020.
- 6.9% of diabetes-related DALYs and 3.0% of cardiovascular-related DALYs were directly attributable to sugary beverages.
- Direct sugar consumption and BMI-mediated pathways both contributed significantly to health risks.
The study emphasized that SSB consumption not only leads to obesity and impaired glucose metabolism but also directly impacts cardiovascular and metabolic health.
Targeted Solutions to Avoid Sugary Drinks:
Experts suggest implementing strategies such as:
- SSB taxes
- Front-of-package labeling
- Public health campaigns
- Education programs on sugar risks
Global disparities indicate the need for region-specific policies to address the rising burden, particularly in low- and middle-income countries like Sub-Saharan Africa, where consumption patterns are shifting rapidly.
The research underscores that reducing SSB intake is a critical step in combating the global epidemic of non-communicable diseases, advocating for immediate action to improve health outcomes and reduce healthcare costs globally.
More Information: Lara-Castor, L., O’Hearn, M., Cudhea, F., Miller, V., Shi, P., Zhang, J., Sharib, J. R., Cash, S. B., Barquera, S., Micha, R., Mozaffarian, & Global Dietary Database (2025). Burdens of type 2 diabetes and cardiovascular disease attributable to sugar-sweetened beverages in 184 countries. Nature Medicine. DOI:10.1038/s41591024033454, https://www.nature.com/articles/s41591-024-03345-4
more recommended stories
Sickle Cell Gene Therapy Access Expands GloballyKey Summary Caring Cross and Boston.
Reducing Alcohol Consumption Could Lower Cancer DeathsKey Takeaways (At a Glance) Long-term.
NeuroBridge AI Tool for Autism Communication TrainingKey Takeaways Tufts researchers developed NeuroBridge,.
Population Genomic Screening for Early Disease RiskKey Takeaways at a Glance Population.
Type 2 Diabetes Risk Identified by Blood MetabolitesKey Takeaways (Quick Summary) Researchers identified.
Microglia Neuroinflammation in Binge DrinkingKey Takeaways (Quick Summary for HCPs).
Durvalumab in Small Cell Lung Cancer: Survival vs CostKey Points at a Glance Durvalumab.
Precision Oncology with Personalized Cancer Drug TherapyKey Takeaways UC San Diego’s I-PREDICT.
Iron Deficiency vs Iron Overload in Parkinson’s DiseaseKey Takeaways (Quick Summary for HCPs).
Rising Chagas Parasite Detected in Borderland Kissing BugsKey Takeaways (At a Glance) Infection.

Leave a Comment